MiR-1246: a New Link of the P53 Family with Cancer and Down Syndrome

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2012 Jul 4

PMID 22751441

Citations 35

Authors

Jun-Ming Liao

Xiang Zhou

Yu Zhang

Hua Lu

Affiliations

Soon will be listed here.

Abstract

Since the discovery of miRNAs, a number of miRNAs have been identified as p53's transcriptional targets. Most of them are involved in regulation of the known p53 functions, such as cell cycle, apoptosis and senescence. Our recent study revealed miR-1246 as a novel target of p53 and its analogs p63 and p73 to suppress the expression of DYRK1A and consequently activate NFAT, both of which are associated with Down syndrome and possibly with tumorigenesis. This finding suggests that miR-1246 might serve as a likely link of the p53 family with Down syndrome. Here, we provide some prospective views on the potential role of the p53 family in Down syndrome via miR-1246 and propose a new p53-miR-1246-DYRK1A-NFAT pathway in cancer.

Citing Articles

Identification and Functional Analysis of Key microRNAs in the Early Extrauterine Environmental Adaptation of Piglets.

Wen M, Li J, Qiu W, Zhang J, Long K, Lu L Int J Mol Sci. 2025; 26(3).

PMID: 39941084 PMC: 11818927. DOI: 10.3390/ijms26031316.

Human Hair Follicle Mesenchymal Stem Cell-Derived Exosomes Attenuate UVB-Induced Photoaging via the miR-125b-5p/TGF-β1/Smad Axis.

Cui H, Fu L, Teng Y, He J, Shen Y, Bian Q Biomater Res. 2025; 29():0121.

PMID: 39807308 PMC: 11725759. DOI: 10.34133/bmr.0121.

A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.

Komitova K, Dimitrov L, Stancheva G, Kyurkchiyan S, Petkova V, Dimitrov S Int J Mol Sci. 2025; 25(24.

PMID: 39769234 PMC: 11676902. DOI: 10.3390/ijms252413468.

Advanced Analysis and Validation of a microRNA Signature for Fanconi Anemia.

Cappelli E, Ravera S, Bertola N, Grilli F, Squillario M, Regis S Genes (Basel). 2024; 15(7).

PMID: 39062599 PMC: 11276059. DOI: 10.3390/genes15070820.

Identification of circulating miRNAs as fracture-related biomarkers.

Della Bella E, Menzel U, Naros A, Kubosch E, Alini M, Stoddart M PLoS One. 2024; 19(5):e0303035.

PMID: 38820355 PMC: 11142570. DOI: 10.1371/journal.pone.0303035.

References

Jin L, Hu W, Jiang C, Wang J, Han C, Chu P . MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci U S A. 2011; 108(38):15840-5. PMC: 3179083. DOI: 10.1073/pnas.1019312108. View

Okamoto S, Mukaida N, Yasumoto K, Rice N, Ishikawa Y, Horiguchi H . The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem. 1994; 269(11):8582-9. View

Suzuki H, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K . Modulation of microRNA processing by p53. Nature. 2009; 460(7254):529-33. DOI: 10.1038/nature08199. View

Karlen S, DErcole M, Sanderson C . Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0. Blood. 1996; 88(1):211-21. View

Wu X, Nguyen B, Dziunycz P, Chang S, Brooks Y, Lefort K . Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature. 2010; 465(7296):368-72. PMC: 3050632. DOI: 10.1038/nature08996. View

Knouf E, Garg K, Arroyo J, Correa Y, Sarkar D, Parkin R . An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res. 2011; 40(2):499-510. PMC: 3258134. DOI: 10.1093/nar/gkr731. View

Ball M, Nuttall K . Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia. Ann Neurol. 1980; 7(5):462-5. DOI: 10.1002/ana.410070512. View

Rooney J, Sun Y, Glimcher L, Hoey T . Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol. 1995; 15(11):6299-310. PMC: 230882. DOI: 10.1128/MCB.15.11.6299. View

Roizen N, Patterson D . Down's syndrome. Lancet. 2003; 361(9365):1281-9. DOI: 10.1016/S0140-6736(03)12987-X. View

10.

Zipursky A . Transient leukaemia--a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol. 2003; 120(6):930-8. DOI: 10.1046/j.1365-2141.2003.04229.x. View

11.

Malkin D, Brown E, Zipursky A . The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome. Cancer Genet Cytogenet. 2000; 116(1):1-5. DOI: 10.1016/s0165-4608(99)00072-2. View

12.

Park J, Song W, Chung K . Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell Mol Life Sci. 2009; 66(20):3235-40. PMC: 11115655. DOI: 10.1007/s00018-009-0123-2. View

13.

Donehower L, Harvey M, Slagle B, McArthur M, Montgomery Jr C, Butel J . Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356(6366):215-21. DOI: 10.1038/356215a0. View

14.

Marques-Salles T, Mkrtchyan H, Leite E, Soares-Ventura E, Muniz M, Silva E . Complex karyotype defined by molecular cytogenetic FISH and M-FISH in an infant with acute megakaryoblastic leukemia and neurofibromatosis. Cancer Genet Cytogenet. 2010; 200(2):167-9. DOI: 10.1016/j.cancergencyto.2010.03.003. View

15.

Dolganov G, Bort S, Lovett M, Burr J, Schubert L, Short D . Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood. 1996; 87(8):3316-26. View

16.

Boominathan L . The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One. 2010; 5(5):e10615. PMC: 2868896. DOI: 10.1371/journal.pone.0010615. View

17.

Stranick K, Payvandi F, Zambas D, Umland S, Egan R, Billah M . Transcription of the murine interleukin 5 gene is regulated by multiple promoter elements. J Biol Chem. 1995; 270(35):20575-82. DOI: 10.1074/jbc.270.35.20575. View

18.

Bohlig L, Friedrich M, Engeland K . p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res. 2010; 39(2):440-53. PMC: 3025554. DOI: 10.1093/nar/gkq796. View

19.

Hammerle B, Elizalde C, Galceran J, Becker W, Tejedor F . The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications. J Neural Transm Suppl. 2004; (67):129-37. DOI: 10.1007/978-3-7091-6721-2_11. View

20.

de la Monte S, Sohn Y, Ganju N, Wands J . P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest. 1998; 78(4):401-11. View